Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine, whether there is clinical benefit of using fdg-PET/CT (F-18-fluorodeoxyglucose- positron emission tomography/computed tomography)compared to contrast-enhance...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Turku University Hospital
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT06994195 · Epithelial Ovarian Cancer, Fallopian Tube Cancer, and more
NCT05377996 · Triple Negative Breast Cancer, Breast Cancer, and more
NCT06915025 · Epithelial Ovarian Cancer, Ovarian Cancer, and more
NCT06710548 · Ovarian Cancer, Advanced Ovarian Carcinoma, and more
Turku University hospital
Turku
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions